Clovis Oncology, Inc. (NASDAQ:CLVS) will announce its fourth quarter/year end 2012 financial results on Thursday, February 28, 2013, after the close of the U.S. financial markets. Clovis’ senior management will host a conference call and live audio webcast on Thursday, February 28, at 4:30 p.m. ET to discuss the company’s results in greater detail.
The conference call is being webcast and can be accessed from the Clovis Oncology website at www.clovisoncology.com. A replay of the webcast will be available for 30 days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, and has additional offices in San Francisco, California, and Cambridge, UK.
|Obagi Medical Products to Report Fourth Quarter and Year End 2012 Financial Results and Host a Conference Call on March 14 (2013/2/21)|
|Columbia Laboratories to Discuss Fourth Quarter and Year-End 2012 Financial Results on March 14 Conference Call (2013/3/4)|
|GenVec To Release Fourth Quarter And Year-end 2012 Financial Results And Conduct A Conference Call On March 22, 2013 (2013/3/15)|
|Tesla Motors Announces Date for Fourth Quarter & Year-End 2012 Financial Results (2013/2/11)|
|Tesla Motors Releases Fourth Quarter & Year-End 2012 Financial Results (2013/2/20)|
|The Dolan Company To Report Fourth Quarter & Year-End 2012 Financial Results on March 8, 2013 (2013/3/7)|
|Clovis Oncology to Announce First Quarter 2013 Financial Results and Host Webcast Conference Call on May 7 (2013/4/23)|
|BG Medicine to Announce Fourth Quarter and Year-End 2012 Financial Results and Host Conference Call on Wednesday, March 13, 2013 (2013/3/6)|
|Genomic Health to Announce Fourth Quarter and Year-End 2012 Financial Results and Host Conference Call on Wednesday, February 6, 2013 (2013/1/30)|
|Response Genetics, Inc. to Release Fourth Quarter and Year-End 2012 Financial Results and Host Conference Call on March 21, 2013 (2013/3/7)|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)|
|P||Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)|
|P||Morningstar Stock Analyst Reports (full research on 2,000 stocks)|
|P||Morningstar Stock and Fund Stewardship Grades|
|P||Portfolio Manager (advanced with 10 x-ray analyses, including guidance)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.